Potential Benefits of Nobiletin, A Citrus Flavonoid, Against Alzheimer's Disease and Parkinson's Disease

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2019 Jul 13

PMID 31295812

Citations 72

Authors

Akira Nakajima

Yasushi Ohizumi

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD), which is characterized by the presence of amyloid-β (Aβ) plaques and neurofibrillary tangles, accompanied by neurodegeneration, is the most common form of age-related neurodegenerative disease. Parkinson's disease (PD) is the second most common neurodegenerative disease after AD, and is characterized by early prominent loss of dopaminergic neurons in the substantia nigra pars compacta. As currently available treatments are not able to significantly alter the progression of these diseases, successful therapeutic and preventive interventions are strongly needed. In the course of our survey of substances from natural resources having anti-dementia and neuroprotective activity, we found nobiletin, a polymethoxylated flavone from the peel of Citrus depressa. Nobiletin improved cognitive deficits and the pathological features of AD, such as Aβ pathology, hyperphosphorylation of tau, and oxidative stress, in animal models of AD. In addition, nobiletin improved motor and cognitive deficits in PD animal models. These observations suggest that nobiletin has the potential to become a novel drug for the treatment and prevention of neurodegenerative diseases such as AD and PD.

Citing Articles

Nobiletin and Eriodictyol Suppress Release of IL-1β, CXCL8, IL-6, and MMP-9 from LPS, SARS-CoV-2 Spike Protein, and Ochratoxin A-Stimulated Human Microglia.

Tsilioni I, Kempuraj D, Theoharides T Int J Mol Sci. 2025; 26(2.

PMID: 39859348 PMC: 11766385. DOI: 10.3390/ijms26020636.

Exploring role of citrus fruits in comorbid neurodegenerative disorders associated with psoriasis.

Ali A, Chaudhary A, Sharma A, Siddiqui N, Anurag , Parihar V Metab Brain Dis. 2024; 40(1):62.

PMID: 39671136 DOI: 10.1007/s11011-024-01479-5.

Activation of Extracellular Signal-Regulated Kinase 2 and cAMP Response Element-Binding Protein in Cultured Neurons by the Macrocyclic Ellagitannin Oenothein B.

Okuyama S, Yoshimura M, Amakura Y, Nakajima M, Furukawa Y NeuroSci. 2024; 3(3):387-394.

PMID: 39483426 PMC: 11523700. DOI: 10.3390/neurosci3030028.

Hepatoprotective effect of Nobiletin against 5-fluorouracil induce hepatotoxicity.

Yahya S, Al-Shawi N Curr Res Pharmacol Drug Discov. 2024; 7:100199.

PMID: 39411523 PMC: 11474214. DOI: 10.1016/j.crphar.2024.100199.

Schisandrin A Alleviates Inflammation and Oxidative Stress in Aβ25-35-Induced Alzheimer's Disease in Vitro Model.

Jia S, Guan H, Zhang S, Li Q Actas Esp Psiquiatr. 2024; 52(5):724-732.

PMID: 39403912 PMC: 11474961. DOI: 10.62641/aep.v52i5.1680.

References

Tang Y, Shimizu E, Dube G, Rampon C, Kerchner G, Zhuo M . Genetic enhancement of learning and memory in mice. Nature. 1999; 401(6748):63-9. DOI: 10.1038/43432. View

Cammarota M, Bevilaqua L, Ardenghi P, Paratcha G, Levi de Stein M, Izquierdo I . Learning-associated activation of nuclear MAPK, CREB and Elk-1, along with Fos production, in the rat hippocampus after a one-trial avoidance learning: abolition by NMDA receptor blockade. Brain Res Mol Brain Res. 2000; 76(1):36-46. DOI: 10.1016/s0169-328x(99)00329-0. View

Alonso M, Viola H, Izquierdo I, Medina J . Aversive experiences are associated with a rapid and transient activation of ERKs in the rat hippocampus. Neurobiol Learn Mem. 2001; 77(1):119-24. DOI: 10.1006/nlme.2000.4000. View

Adams J, Sweatt J . Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol. 2002; 42:135-63. DOI: 10.1146/annurev.pharmtox.42.082701.145401. View

Vitolo O, SantAngelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M . Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci U S A. 2002; 99(20):13217-21. PMC: 130613. DOI: 10.1073/pnas.172504199. View

Hozumi S, Nakagawasai O, Tan-No K, Niijima F, Yamadera F, Murata A . Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy. Behav Brain Res. 2002; 138(1):9-15. DOI: 10.1016/s0166-4328(02)00183-3. View

Esteban J, Shi S, Wilson C, Nuriya M, Huganir R, Malinow R . PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity. Nat Neurosci. 2003; 6(2):136-43. DOI: 10.1038/nn997. View

Oddo S, Caccamo A, Shepherd J, Murphy M, Golde T, Kayed R . Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003; 39(3):409-21. DOI: 10.1016/s0896-6273(03)00434-3. View

Oddo S, Caccamo A, Kitazawa M, Tseng B, LaFerla F . Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging. 2003; 24(8):1063-70. DOI: 10.1016/j.neurobiolaging.2003.08.012. View

10.

Yasuda T, Yoshimura Y, Yabuki H, Nakazawa T, Ohsawa K, Mimaki Y . Urinary metabolites of nobiletin orally administered to rats. Chem Pharm Bull (Tokyo). 2003; 51(12):1426-8. DOI: 10.1248/cpb.51.1426. View

11.

Mishizen-Eberz A, Rissman R, Carter T, Ikonomovic M, Wolfe B, Armstrong D . Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology. Neurobiol Dis. 2004; 15(1):80-92. DOI: 10.1016/j.nbd.2003.09.016. View

12.

Sweatt J . Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol. 2004; 14(3):311-7. DOI: 10.1016/j.conb.2004.04.001. View

13.

Tanaka S, Sato T, Akimoto N, Yano M, Ito A . Prevention of UVB-induced photoinflammation and photoaging by a polymethoxy flavonoid, nobiletin, in human keratinocytes in vivo and in vitro. Biochem Pharmacol. 2004; 68(3):433-9. DOI: 10.1016/j.bcp.2004.04.006. View

14.

Yoshimizu N, Otani Y, Saikawa Y, Kubota T, Yoshida M, Furukawa T . Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation. Aliment Pharmacol Ther. 2004; 20 Suppl 1:95-101. DOI: 10.1111/j.1365-2036.2004.02082.x. View

15.

Billings L, Oddo S, Green K, McGaugh J, LaFerla F . Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron. 2005; 45(5):675-88. DOI: 10.1016/j.neuron.2005.01.040. View

16.

Snyder E, Nong Y, Almeida C, Paul S, Moran T, Choi E . Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci. 2005; 8(8):1051-8. DOI: 10.1038/nn1503. View

17.

Butterfield D, Poon H . The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp Gerontol. 2005; 40(10):774-83. DOI: 10.1016/j.exger.2005.05.007. View

18.

Iwata N, Higuchi M, Saido T . Metabolism of amyloid-beta peptide and Alzheimer's disease. Pharmacol Ther. 2005; 108(2):129-48. DOI: 10.1016/j.pharmthera.2005.03.010. View

19.

Nagase H, Yamakuni T, Matsuzaki K, Maruyama Y, Kasahara J, Hinohara Y . Mechanism of neurotrophic action of nobiletin in PC12D cells. Biochemistry. 2005; 44(42):13683-91. DOI: 10.1021/bi050643x. View

20.

Nagase H, Omae N, Omori A, Nakagawasai O, Tadano T, Yokosuka A . Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities. Biochem Biophys Res Commun. 2005; 337(4):1330-6. DOI: 10.1016/j.bbrc.2005.10.001. View